Form 4 for INFQ Infleqtion, Inc.
Accepted 2026-02-18 00:00:00 ET · period of report 2026-02-13 · accession 0002108532-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-18 | 2026-02-13 | INFQ | Gokhale Pranav | CTO | A - Grant | $0.00 | +2.34M | 2.34M | New | $0 |
| DM | 2026-02-18 | 2026-02-13 | INFQ | Gokhale Pranav | CTO | A - Grant | $0.00 | +559.4K | 3,859 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-13 | A | A | 2,338,980 | $0.00 | 2,338,980 | D | — | — | (F1) Received pursuant to the Agreement and Plan of Merger and Reorganization, dated as of September 8, 2025, by and among Churchill Capital Corp X, a Delaware corporation now known as Infleqtion, Inc. ("Acquiror"), AH Merger Sub I, Inc., a direct, wholly-owned Subsidiary of Acquiror ("Merger Sub I"), AH Merger Sub II, LLC, a direct, wholly-owned Subsidiary of Acquiror ("Merger Sub II" and together with Merger Sub I, "Merger Subs") and ColdQuanta, Inc. (the "Company") pursuant to which (a) Merger Sub I was merged with and into the Company, and the Company continued as the surviving corporation and immediately thereafter, (b) the Company merged with and into Merger Sub II, and Merger Sub II became the surviving company and continued in existence as a wholly-owned subsidiary of Acquiror (collectively, the "Mergers"). In connection with the Mergers, Acquiror changed its name to Infleqtion, Inc. (the "Issuer"). |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-02-13 | A | A | 347 | — | 347 | D | $0.67 · — to 2033-05-30 | 347 Common Stock | (F3) Pursuant to the Mergers, the legacy stock options of the Company were automatically converted into the right to receive stock options of the Issuer with the same terms and conditions. (F4) Fully vested. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-02-13 | A | A | 293,828 | $0.00 | 293,828 | D | $13.22 · — to 2036-02-12 | 293,828 Common Stock | (F5) 1/48th of the shares underlying the option vest in equal monthly installments commencing on February 17, 2026, subject to the Reporting Person's continued service through each vesting date. |
| 4 | Derivative | Stock Option (Right to Buy) | 2026-02-13 | A | A | 781 | — | 781 | D | $0.9 · — to 2034-06-05 | 781 Common Stock | (F3) Pursuant to the Mergers, the legacy stock options of the Company were automatically converted into the right to receive stock options of the Issuer with the same terms and conditions. (F4) Fully vested. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-02-13 | A | A | 260,552 | — | 260,552 | D | $0.67 · — to 2032-08-25 | 260,552 Common Stock | (F3) Pursuant to the Mergers, the legacy stock options of the Company were automatically converted into the right to receive stock options of the Issuer with the same terms and conditions. (F2) 50% of the stock option vested and became exercisable on May 10, 2024, and thereafter the remainder vest in 24 equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. |
| 6 | Derivative | Stock Option (Right to Buy) | 2026-02-13 | A | A | 3,859 | — | 3,859 | D | $0.9 · — to 2034-03-10 | 3,859 Common Stock | (F3) Pursuant to the Mergers, the legacy stock options of the Company were automatically converted into the right to receive stock options of the Issuer with the same terms and conditions. (F4) Fully vested. |